Background Multidrug resistance (MDR) in microorganisms has culminated in major health
crisis globally and accounts for approximately 700,000 morbidities every year. Recently …

Pharmaceutical biology perceives plants as 'bio-factories' of potentially valuable therapeutic
compounds. But slow growing rate and harvesting of rare endangered species pose a risk …

Over the last few decades, many of the existing drugs used to treat infectious diseases have
become increasingly ineffective due to the global emergence of antimicrobial resistance …

Multidrug drug resistant bacteria are becoming increasingly problematic particularly in the
under developed countries of the world. The most important microorganisms that have seen …

Presently, several drug discovery investigations on therapeutic management of human
health are aimed at bioprospecting for microorganisms, especially endophytic microbes of …

Resistance in micro-organisms against antimicrobial compounds is an emerging
phenomenon in the modern era as compared to the traditional world which brings new …

Endophytes, microorganisms that colonize internal tissues of all plant species, create a huge
biodiversity with yet unknown novel natural products, presumed to push forward the frontiers …

The war on multidrug resistance (MDR) has resulted in the greatest loss to the world's
economy. Antibiotics, the bedrock, and wonder drug of the 20th century have played a …

Endophytes are an endosymbiotic group of microorganisms that colonize in plants and
microbes that can be readily isolated from any microbial or plant growth medium. They act …

Plant-endophyte associations represent an inexhaustible source of novel metabolites,
exhibiting significance in environment, agriculture and pharmaceutical perspectives. The …